CLINICAL IMPLICATIONS OF COPY NUMBER ALTERATION DETECTION USING PANEL-BASED NEXT-GENERATION SEQUENCING DATA IN MYELODYSPLASTIC SYNDROME
Introduction: Recurrent somatic mutations are found in about 90 % of the MDS patients, and some of the mutations are known to have a prognostic value at various clinical stages of myelodysplastic syndrome (MDS). However, there are no specific guidelines for the assessment of CNAs, and the CNA test i...
Main Authors: | S.-H. Jung, Y.-J. Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048924000165 |
Similar Items
-
Analysis of Copy Number Variations in Solid Tumors Using a Next Generation Sequencing Custom Panel
by: Marta Vives-Usano, et al.
Published: (2021-05-01) -
Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing
by: Elisabetta Anna Tendi, et al.
Published: (2023-07-01) -
Detection of Copy Number Alterations Using Single Cell Sequencing
by: Knouse, Kristin Ann, et al.
Published: (2018) -
DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data
by: Yeeok Kang, et al.
Published: (2018-10-01) -
CNV-Z; a new tool for detecting copy number variation in next generation sequencing data
by: Emma Adolfsson, et al.
Published: (2023-12-01)